David Albandea‐Rodríguez

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Universidad Autónoma de Madrid(Current)

Instituto de Investigaciones Biomédicas Sols-Morreale

David Albandea‐Rodríguez is an author at Universidad Autónoma de Madrid specializing in oncology, sorafenib therapy, and receptor tyrosine kinase signaling.

ORCID

Publications per year

2021–2024

Publications

ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology

Marta Ortega‐Muelas, O. Roche, Diego M. Fernández‐Aroca et al. · Journal of Cellular and Molecular Medicine · 2021 · 12 citations · Full text

Medicine, Molecular Biology, Oncology +17

Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids

Pilar Bustamante‐Madrid, Antonio Barbáchano, David Albandea‐Rodríguez et al. · Cell Death and Disease · 2024 · 11 citations · Full text

Life Sciences, Cell Biology, Oncology +15

1–2 of 2